Varicella zoster virus encephalitis: a potentially serious complication during treatment with vedolizumab.

Miriam Celada-Sendino,Lorena Carballo-Folgoso,Ruth de Francisco,Isabel Pérez-Martínez,Andrés Castaño-García,Sabino Riestra

Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva（2022）

引用 0|浏览0

暂无评分

摘要

Vedolizumab is a monoclonal antibody that has demonstrated efficacy and a good safety profile in patients with inflammatory bowel disease. Varicella zoster virus encephalitis is a potentially serious complication not previously described with its use, highlighting the importance of vaccination, as well as early diagnosis and treatment of infections in this type of patients.

查看译文

关键词

Vedolizumab, Encephalitis, Varicella zoster virus, Crohn's disease

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要